Genesys Capital


Genesys Capital invests in and builds companies in the high-growth sectors of biotechnology, pharmaceuticals and medical technology. We have a proven track record of identifying emerging bioscience opportunities, and transforming them into commercially successful companies. That track record is fuelled by robust industry relationships, broad business expertise, and a deep understanding of the life sciences sector.Genesys has generated more than 18 exits from 36 portfolio companies and has invested more than $200M. Our third institutional fund is closed and we’re actively considering new, high-potential life science companies for investment


Series B

Focus area

BioTech, Healthcare




Name: Kelly Holman
Title: Managing Director

Enquire about our services

  • This field is for validation purposes and should be left unchanged.

Wondering how much your SR&ED Claim is going to be?

With CEWS and other government support programs, your SR&ED claim might be affected. Calculate it now for free with our SR&ED calculator